Substance
LAZERTINIB MESYLATE
Global reference: every product and company linked to this substance.
- cas: 2411549-88-5
- ncit: C210427
- pubchem_cid: 163203547
- unii: WUT449BEG5
JNJ-73841937-ZCY · LAZCLUZE · LAZERTINIB MESILATE HYDRATE [JAN] · LAZERTINIB MESYLATE [USAN] · Lazertinib mesylate monohydrate [WHO-DD] · R-605024 · R605024 · YH25448AM
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | LAZCLUZE | Q2 2026 | $289.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (1)
- LAZCLUZE · JOHNSON & JOHNSON COMMON STOCK